Compounded semaglutide
Sold by MaxLife · every compounded semaglutide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
Recorded initial charges
First month
$100
first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.
| Medication · Starting price · recorded initial monthly payment | $100 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Starting price “Semaglutide One receptor · MaxLife patients have lost up to 46.9 lbs in 52 weeks Starting at $100/mo” | Per month$100 | Charged today$100 |
Price sources
- Starting price · maxlife.com — read September 2026
We earn nothing from this link. It opens MaxLife's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- September 2026 — Entry added to the register
Sourcing and terms
| States | All 50 states |
|---|---|
| Prescriber | Both |
| Cancellation | No. MaxLife programs do not require a long-term contract. We offer different billing periods, and you may cancel anytime by submitting a cancellation notice at least 30 days before your next billing period begins. Please note that medication costs are not refundable. |
Not yet checked: pharmacy, membership and consult fee.
Recorded from maxlife.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2026 — All facts for this candidate came from a single, unusually thorough homepage FAQ block; no separate pricing or terms page was linked in the fetched output.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.